Series A is a commercial test, not a product test.

Printed pitch deck pages and revenue charts under a desk lamp

There was a time when a strong team, a working prototype, and a large market cleared a Series A. That time is over, and in health innovation it has been over for a while. The question investors ask has changed from can this be built to can this be sold, and they expect the answer in your numbers before they will price the round.

In practice, the bar looks like this: several million dollars in sales, credible conversion evidence, and a pipeline that survives a partner's diligence call to a buyer you did not hand-pick. Founders routinely discover this bar twelve months too late, after spending their seed round making the product better instead of making the company fundable.

The round does not clear on what the product could do. It clears on what the company has already sold.

Why health innovation makes the test harder

Every part of the commercial proof is slower to earn in this market. Hospital sales cycles run six to twelve months. Buying committees include clinicians, IT, security, finance, and procurement, and any one of them can stall a deal. Evidence expectations mean your first customers often want a pilot before a purchase order, which adds another cycle. Meanwhile a seed-stage company is holding twelve to eighteen months of runway.

Put those numbers side by side and the conclusion is uncomfortable: a health-innovation company that starts building its commercial engine after the product is finished will usually run out of road before the proof exists.

What to do with the next twelve months

  • Treat commercial proof as a product requirement. Sequence the roadmap around what buyers must see, not what engineering prefers to build next.
  • Start the sales clock now. If the cycle is nine months, deals opened this quarter are the traction slide in next year's raise.
  • Instrument everything. Conversion by stage, cycle length, and pipeline coverage are the metrics a partner meeting will actually interrogate.
  • Design pilots to convert. A pilot without pre-agreed success criteria and a purchase path is a donation, not traction.

None of this requires a big sales team. It requires a working engine: a plan, playbooks, systems, evidence, and access to buyers, run at founder speed. That is a build project with a known shape, and it is exactly the work we do.

← All insights Talk to us about your raise
Where does your proof stand?

Get an operator's read on your Series A readiness.

info@sksgrowthpartners.com